SCANTILY PAD

Product NDC
81953-100
11-digit product format
819530100
Labeler code
81953
Product ID
81953-100_48c4d99f-9b27-7bf3-e063-6394a90a57ee
Type
HUMAN OTC DRUG
Nonproprietary name
Acne Treatment
Dosage form
LIQUID
Route
TOPICAL
Labeler
Dermala Inc
Application
M006
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2021-06-01
Substance
SALICYLIC ACID
Active strength
.01 mg/mg
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81953-100-012024-01-30C16284748780-11030e365-1b19-111a-e063-dadaa90a10e2c5145f1d-78f7-22b4-e053-2a95a90a5c59

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81953-100-01SCANTILY PAD50 mg in 1 JARLIQUID506

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81953-100SCANTILY PAD (ACNE TREATMENT) LIQUID [DERMALA INC]5Current NDC, Legacy NDC, 1 package rows20241212_c5145f1d-78f7-22b4-e053-2a95a90a5c59.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
81953-100-018195301000150 mg in 1 JAR (81953-100-01) 50 mg2021-06-010000-00-00NoNoCurrent